Venture Certified
| 혁신성장유형 | 2021-09-29 ~ 2024-09-28 | 20210929030018 | 2021-09-29 |
| 혁신성장유형 | 2024-09-29 ~ 2027-09-28 | 20240910030042 | 2021-09-29 |
Revenue CAGR +1191.2%
| Item | 2023 | 2022 |
|---|---|---|
| Revenue | 0.3B | 0.0B |
| Operating Profit | -6.3B | -3.4B |
| Net Profit | -2.6B | -0.6B |
| Total Assets | 2.0B | 4.0B |
| Total Liabilities | 1.4B | 0.7B |
| Total Equity | 0.6B | 3.2B |
Operating Loss: Op. profit -6B
2 Consecutive Years of Net Loss
Debt Ratio Surge (+198pp YoY)
▲ 1191.2%
▼ 85.7%
▲ 85.6%
▲ 905.8%
▼ 2212.6%
| Name | Position | Role |
|---|---|---|
| 박명찬 | 대표이사 | 대표 |
| Regular Employees | 8persons |
| CEO | 박명찬 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "경남 김해시",
"ceo_name": "박명찬",
"certificate": [
{
"cert_number": "20210929030018",
"changes": "",
"disclosure_date": "2021-09-29",
"first_cert_date": "2021-09-29",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2021-09-29 ~ 2024-09-28"
},
{
"cert_number": "20240910030042",
"changes": "대표자",
"disclosure_date": "2024-09-10",
"first_cert_date": "2021-09-29",
"no": "2",
"type": "혁신성장유형",
"valid_period": "2024-09-29 ~ 2027-09-28"
}
],
"company_name": "(주)유메드",
"financials": {
"2022": {
"capital_stock": 108985000,
"cost_of_sales": 0,
"current_assets": 349415000,
"current_liabilities": 70968000,
"gross_profit": 2507000,
"net_income": -57986000,
"net_income_bs": -57986000,
"non_current_assets": 46340000,
"non_current_liabilities": 0,
"non_operating_expenses": 8000,
"non_operating_income": 280446000,
"operating_profit": -338424000,
"revenue": 2507000,
"sga_expenses": 340931000,
"total_assets": 395756000,
"total_equity": 324787000,
"total_liabilities": 70968000
},
"2023": {
"capital_stock": 108985000,
"cost_of_sales": 0,
"current_assets": 113542000,
"current_liabilities": 112773000,
"gross_profit": 32371000,
"net_income": -261462000,
"net_income_bs": -261462000,
"non_current_assets": 88954000,
"non_current_liabilities": 26398000,
"non_operating_expenses": 1427000,
"non_operating_income": 368304000,
"operating_profit": -628339000,
"revenue": 32371000,
"sga_expenses": 660710000,
"total_assets": 202497000,
"total_equity": 63325000,
"total_liabilities": 139171000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [],
"phone": "010-2090-****",
"source": "pg_migration"
}{
"address": "경남 김해시 주촌면 소망길 88 (주폰명, 김해의생명센터단지)생명센터동209호)",
"employee_count": 8,
"establishment_date": "20210419",
"source": "pg_migration",
"workplace_name": "주식회사유메드(U-Med)"
}Data Quality: 80/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| comwel_insurance | 2026-03-05 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |